trending Market Intelligence /marketintelligence/en/news-insights/trending/k0xyDwPOAwJq-DEcs5vtCg2 content esgSubNav
In This List

Cytokinetics finds accounting error, to reissue quarterly statements

Blog

Highlighting the Top Regional Aftermarket Research Brokers by Sector Coverage

Video

COVID-19 Impact & Recovery: Healthcare Outlook for H2 2021

Blog

Corporate Credit Risk Trends in Developing Markets: A Loss Given Default (LGD) Perspective

Blog

Corporate Credit Risk Trends in Developing Markets: A Probability of Default Perspective


Cytokinetics finds accounting error, to reissue quarterly statements

Cytokinetics Inc. said it identified an error in its financial statements for the three months and nine months ended Sept. 30.

The company erroneously overstated its research and development costs by approximately $1.5 million and recorded an additional $1.5 million in total liabilities in its balance sheet.

Cytokinetics said it will file an amended financial statement as soon as practicable.